Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Aveanna Healthcare Holdings, Inc.
Report date August 20, 2026 · Filed August 24, 2026
Section 16 reporting ended · disclosed 2026-08-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectBy J.H. Whitney VII, L.P. | 0 |
Reported balance
After 2026-08-20 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-08-20 · Sale · Disposed 10,112,125 · Balance 0 F5: On August 20, 2026, J.H. Whitney VII, L.P sold 10,112,125 Shares pursuant to an underwritten secondary offering. F1: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectBy PSA Healthcare Investment Holding LLC | 12,315,892 |
Last balance in matching sequence
After 2026-08-21 transaction · row 7
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 3 · 2026-08-20 · Sale · Disposed 957,918 · Balance 14,565,892 F6: On August 20, 2026, PSA Healthcare Investment Holding LLC sold 957,918 Shares pursuant to an underwritten secondary offering. F1: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Row 7 · 2026-08-21 · Sale · Disposed 2,250,000 · Balance 12,315,892 F10: On August 21, 2026, PSA Healthcare Investment Holding LLC sold 2,250,000 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering. F1: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectBy JHW Iliad Holdings, LLC | 0 |
Reported balance
After 2026-08-20 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2026-08-20 · Sale · Disposed 1,813,795 · Balance 0 F7: On August 20, 2026, JHW Iliad Holdings, LLC sold 1,813,795 Shares pursuant to an underwritten secondary offering. F2: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectBy PSA Iliad Holdings LLC | 0 |
Reported balance
After 2026-08-20 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2026-08-20 · Sale · Disposed 1,426,034 · Balance 0 F8: On August 20, 2026, JHW Iliad Holdings II, LLC sold 190,130 Shares pursuant to an underwritten secondary offering. F1: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectBy JHW Iliad Holdings II, LLC | 0 |
Reported balance
After 2026-08-20 transaction · row 6
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 6 · 2026-08-20 · Sale · Disposed 190,130 · Balance 0 F9: On August 20, 2026, PSA Iliad Holdings LLC sold 1,426,034 Shares pursuant to an underwritten secondary offering. F2: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F3: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2026-08-20 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 F4: Robert M. Williams, Jr is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F2: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F3: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F4: Robert M. Williams, Jr is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F5: On August 20, 2026, J.H. Whitney VII, L.P sold 10,112,125 Shares pursuant to an underwritten secondary offering.
F6: On August 20, 2026, PSA Healthcare Investment Holding LLC sold 957,918 Shares pursuant to an underwritten secondary offering.
F7: On August 20, 2026, JHW Iliad Holdings, LLC sold 1,813,795 Shares pursuant to an underwritten secondary offering.
F8: On August 20, 2026, JHW Iliad Holdings II, LLC sold 190,130 Shares pursuant to an underwritten secondary offering.
F9: On August 20, 2026, PSA Iliad Holdings LLC sold 1,426,034 Shares pursuant to an underwritten secondary offering.
F10: On August 21, 2026, PSA Healthcare Investment Holding LLC sold 2,250,000 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.
Caris Life Sciences, Inc.
Report date June 20, 2025 · Filed June 23, 2025
Jointly reported with J H Whitney VI L P, J. H. Whitney Equity Partners VI, LLC, VIGANO PAUL R
Section 16 reporting ended · disclosed 2025-06-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 20,256,615 |
Reported balance
After 2025-06-20 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-06-20 · Conversion · Acquired 12,516,834 · Balance 20,256,615 F1: Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock. F2: The securities reported herein are held of record by J.H. Whitney VI L.P. J.H. Whitney Equity Partners VI, LLC is the sole general partner of J.H. Whitney VI L.P. Paul R. Vigano and Robert M. Williams, Jr., as the managing members of J.H. Whitney Equity Partners VI, LLC, share voting and investment power with respect to the shares held by J.H. Whitney VI L.P. Each of J.H. Whitney Equity Partners VI, LLC, Paul R. Vigano and Robert M. Williams, Jr. disclaims beneficial ownership of such securities except to the extent of its or his pecuniary interest therein. |
| Series A Preferred StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2025-06-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-20 · Conversion · Disposed 50,067,334 · Balance 0 F1: Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock. F2: The securities reported herein are held of record by J.H. Whitney VI L.P. J.H. Whitney Equity Partners VI, LLC is the sole general partner of J.H. Whitney VI L.P. Paul R. Vigano and Robert M. Williams, Jr., as the managing members of J.H. Whitney Equity Partners VI, LLC, share voting and investment power with respect to the shares held by J.H. Whitney VI L.P. Each of J.H. Whitney Equity Partners VI, LLC, Paul R. Vigano and Robert M. Williams, Jr. disclaims beneficial ownership of such securities except to the extent of its or his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of preferred stock automatically converted into 0.25 shares of Common Stock of the Issuer upon the closing of the initial public offering of the Issuer's Common Stock.
F2: The securities reported herein are held of record by J.H. Whitney VI L.P. J.H. Whitney Equity Partners VI, LLC is the sole general partner of J.H. Whitney VI L.P. Paul R. Vigano and Robert M. Williams, Jr., as the managing members of J.H. Whitney Equity Partners VI, LLC, share voting and investment power with respect to the shares held by J.H. Whitney VI L.P. Each of J.H. Whitney Equity Partners VI, LLC, Paul R. Vigano and Robert M. Williams, Jr. disclaims beneficial ownership of such securities except to the extent of its or his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2025 Filed May 12, 2025 15:22 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 2,015 | $5.65 | $11,384.75 |
DisclosureSEC source: 0000950170-25-068770 · ownership.xml · nonDerivative · entry 5 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,647,510 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.71. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 09, 2025 Filed May 12, 2025 15:22 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 4,034 | $5.65 | $22,792.10 |
DisclosureSEC source: 0000950170-25-068770 · ownership.xml · nonDerivative · entry 3 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,319,404 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.71. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 08, 2025 Filed May 12, 2025 15:22 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 917 | $5.84 | $5,355.28 |
DisclosureSEC source: 0000950170-25-068770 · ownership.xml · nonDerivative · entry 10 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 545,330 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $6.10. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 08, 2025 Filed May 12, 2025 15:22 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 2,435 | $5.84 | $14,220.40 |
DisclosureSEC source: 0000950170-25-068770 · ownership.xml · nonDerivative · entry 8 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,448,785 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $6.10. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 08, 2025 Filed May 12, 2025 15:22 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 8,745 | $5.84 | $51,070.80 |
DisclosureSEC source: 0000950170-25-068770 · ownership.xml · nonDerivative · entry 6 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,202,346 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $6.10. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 08, 2025 Filed May 12, 2025 15:22 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 26,308 | $5.84 | $153,638.72 |
DisclosureSEC source: 0000950170-25-068770 · ownership.xml · nonDerivative · entry 4 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,649,525 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $6.10. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| May 08, 2025 Filed May 12, 2025 15:22 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 52,656 | $5.84 | $307,511.04 |
DisclosureSEC source: 0000950170-25-068770 · ownership.xml · nonDerivative · entry 2 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,323,438 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $6.10. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 22:04 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 142 | $5.63 | $799.46 |
DisclosureSEC source: 0000950170-25-050733 · ownership.xml · nonDerivative · entry 11 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 546,247 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 22:04 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 378 | $5.63 | $2,128.14 |
DisclosureSEC source: 0000950170-25-050733 · ownership.xml · nonDerivative · entry 9 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,220 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 22:04 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 1,356 | $5.63 | $7,634.28 |
DisclosureSEC source: 0000950170-25-050733 · ownership.xml · nonDerivative · entry 7 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,211,091 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 22:04 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 4,080 | $5.63 | $22,970.40 |
DisclosureSEC source: 0000950170-25-050733 · ownership.xml · nonDerivative · entry 5 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,675,833 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 22:04 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 8,166 | $5.63 | $45,974.58 |
DisclosureSEC source: 0000950170-25-050733 · ownership.xml · nonDerivative · entry 3 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,376,094 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:04 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 63 | $5.63 | $354.69 |
DisclosureSEC source: 0000950170-25-050733 · ownership.xml · nonDerivative · entry 10 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 546,389 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.67. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:04 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 167 | $5.63 | $940.21 |
DisclosureSEC source: 0000950170-25-050733 · ownership.xml · nonDerivative · entry 8 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,598 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.67. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:04 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 559 | $5.63 | $3,147.17 |
DisclosureSEC source: 0000950170-25-050733 · ownership.xml · nonDerivative · entry 6 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,212,447 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.67. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:04 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 1,803 | $5.63 | $10,150.89 |
DisclosureSEC source: 0000950170-25-050733 · ownership.xml · nonDerivative · entry 4 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,679,913 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.67. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:04 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 3,610 | $5.63 | $20,324.30 |
DisclosureSEC source: 0000950170-25-050733 · ownership.xml · nonDerivative · entry 2 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,384,260 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.67. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 25, 2025 Filed Mar 26, 2025 23:21 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 2 | $5.64 | $11.28 |
DisclosureSEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 11 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 546,452 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.63 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 25, 2025 Filed Mar 26, 2025 23:21 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 5 | $5.64 | $28.20 |
DisclosureSEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 9 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,765 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.63 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 25, 2025 Filed Mar 26, 2025 23:21 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 19 | $5.64 | $107.16 |
DisclosureSEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 7 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,213,046 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.63 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 25, 2025 Filed Mar 26, 2025 23:21 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 58 | $5.64 | $327.12 |
DisclosureSEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 5 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,681,716 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.63 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 25, 2025 Filed Mar 26, 2025 23:21 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 116 | $5.64 | $654.24 |
DisclosureSEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 3 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,387,870 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.63 to $5.65. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 23:21 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 3 | $5.63 | $16.89 |
DisclosureSEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 10 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 546,454 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 23:21 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 8 | $5.63 | $45.04 |
DisclosureSEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 8 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,770 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 23:21 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 29 | $5.63 | $163.27 |
DisclosureSEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 6 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,213,065 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 23:21 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 87 | $5.63 | $489.81 |
DisclosureSEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 4 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,681,774 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 23:21 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 173 | $5.63 | $973.99 |
DisclosureSEC source: 0000950170-25-045582 · ownership.xml · nonDerivative · entry 2 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,387,986 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.63. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 20:05 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 817 | $5.46 | $4,460.82 |
DisclosureSEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 11 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 546,457 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 20:05 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 2,170 | $5.46 | $11,848.20 |
DisclosureSEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 9 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,451,778 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 20:05 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 7,792 | $5.46 | $42,544.32 |
DisclosureSEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 7 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,213,094 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 20:05 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 23,438 | $5.46 | $127,971.48 |
DisclosureSEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 5 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,681,861 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 20:05 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 46,912 | $5.46 | $256,139.52 |
DisclosureSEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 3 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,388,159 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:05 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 693 | $5.51 | $3,818.43 |
DisclosureSEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 10 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings II LLC Disclosed balance after: 547,274 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F6 · ownership.nature: J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:05 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 1,842 | $5.51 | $10,149.42 |
DisclosureSEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 8 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Iliad Holdings LLC Disclosed balance after: 1,453,948 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:05 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 6,614 | $5.51 | $36,443.14 |
DisclosureSEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 6 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By JHW Iliad Holdings LLC Disclosed balance after: 5,220,886 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F5 · ownership.nature: Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:05 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 19,897 | $5.51 | $109,632.47 |
DisclosureSEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 4 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By PSA Healthcare Investment Holding LLC Disclosed balance after: 15,705,299 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:05 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | SaleCommon Stock, $0.01 par value | 39,825 | $5.51 | $219,435.75 |
DisclosureSEC source: 0000950170-25-042866 · ownership.xml · nonDerivative · entry 2 WILLIAMS ROBERT M JR · CIK 0001239610 · 10% owner J.H. Whitney VII, L.P. · CIK 0001483044 · 10% owner PSA HEALTHCARE INVESTMENT HOLDING LLC · CIK 0001857907 · 10% owner JHW Iliad Holdings LLC · CIK 0001910617 · 10% owner PSA Iliad Holdings LLC · CIK 0001910404 · 10% owner JHW Iliad Holdings II LLC · CIK 0001910615 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By J.H. Whitney VII, L.P. Disclosed balance after: 31,435,071 F1 · shares: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F4 · ownership.nature: J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.